Skip to main content
Cell Bio Human Tech Co., Ltd logo

Cell Bio Human Tech Co., Ltd — Investor Relations & Filings

Ticker · 318160 ISIN · KR7318160009 KO Professional, scientific and technical activities
Open in API
Filings indexed 146 across all filing types
Latest filing 2025-08-28 Transaction in Own Shar…
Country KR South Korea
Listing KO 318160

About Cell Bio Human Tech Co., Ltd

http://cellbiohumantech.co.kr/en/

Cell Bio Human Tech Co., Ltd. is a company that develops and manufactures advanced nonwoven fabrics for the cosmetics sector. Utilizing cellulose reaction technology, the company produces specialized materials primarily for sheet masks and skincare pads. Its products, derived from various cellulose fibers, are engineered for differentiated performance, offering features such as high transparency and adhesion. The company provides customizable and eco-friendly fabric solutions, with key product lines including PT Cell and S Cell.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from CellBioHumanTech regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This falls under the category of corporate actions related to share buybacks or treasury share management. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct classification for reports concerning the company buying back or selling its own shares, including the termination of trust contracts related to such activities.
2025-08-28 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This falls under the category of company share buyback or treasury share management activities. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct classification for reports concerning the company buying back or selling its own shares.
2025-08-28 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Trust Contract Termination Report' (신탁계약해지결과보고서) filed with the Financial Supervisory Service (FSS) in Korea. It details the termination of a share repurchase trust contract, including the total amount, acquisition history, and the resulting status of treasury shares. This falls under the category of 'Transaction in Own Shares' (POS) as it reports the conclusion of a share buyback program.
2025-08-28 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by CellBioHumanTech. It details the conclusion of a share repurchase trust contract, including the total amount, the number of shares acquired, and the final status of treasury shares. This type of filing, which reports the execution and completion of a share buyback program via a trust, is classified as a 'Transaction in Own Shares' (POS) under the provided schema.
2025-08-28 Korean
[기재정정]주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, CellBioHumanTech, regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). It also includes a correction (정정신고) to a previous filing. Since the document details the company's decision to terminate a share buyback trust agreement, it falls under the category of 'Transaction in Own Shares' (POS), which covers share repurchases and related trust activities.
2025-08-28 Korean
[기재정정]반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Cell Bio Human Tech'. It contains detailed financial information, business descriptions, and management disclosures for the period ending June 30, 2025. Although it is labeled as a 'correction' (정정신고), it is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.